Response to Treatment with Melatonin and Clonazepam versus Placebo in Patients with Burning Mouth Syndrome

Objective: to evaluate the efficacy of melatonin and clonazepam versus placebo in patients with burning mouth syndrome (BMS). Methods: a prospective double-blind study was carried out in patients with BMS and randomized to three groups: melatonin (1 mg once a day), clonazepam (0.5 mg/twice a day), o...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Candela Castillo-Felipe, Asta Tvarijonaviciute, Marina López-Arjona, Luis Pardo-Marin, Eduardo Pons-Fuster, Pia López-Jornet
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2022-04-01
Serija:Journal of Clinical Medicine
Teme:
burning mouth syndrome
pain
xerostomia
sleep
melatonin
clonazepam
Online pristup:https://www.mdpi.com/2077-0383/11/9/2516
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items